This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Uncover practical ways to use your skills to generate cash quickly. Turn your talents into income today!
23,764 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A niche copper miners ETF has surged more than 150% over the past year as AI data center growth boosts copper demand....
The Schwab U.S. Dividend Equity ETF now concentrates 41% of its assets in its top 10 holdings, a shift that could res...
July began with AI-driven headlines shifting attention from headlines to execution. This guide breaks down how stock ...
A potential rollback of steel and aluminum tariffs could reshape costs for major beverage makers and packaging firms....
Planet Labs reports a record Q4 revenue and a backlog eclipsing annual sales, spurring a sharp after hours rally as i...
Ares Capital's dividend looks tempting to many income investors, but sustainability hinges on cash flow, loan quality...
First-quarter 2026 saw a record pace of home equity withdrawals as borrowers leaned on second liens and HELOCs rather...
Netflix posts solid Q1 growth driven by an ad-supported tier, while Comcast faces margin pressure from sports costs a...
On a day of mixed signals, Bank of America and peers moved as tariffs and earnings chatter swirled. This article brea...
When planet labs stock popped today, traders looked for catalysts in a market that often overreacts to headlines. Thi...
Retirement health costs can surprise you. This guide reveals five Medicare myths that costing seniors thousands and p...